SOLVO Biotechnology is the worldwide leading provider of Transporter protein Products and Services. Founded in 1999, SOLVO was the pioneer in commercializing Transporter assays. Through continuous innovation and R&D we managed to keep our leading position on the market and become a major player in the in vitro DMPK and DDI field. We have worked with over 500 clients worldwide and our continuously expanding portfolio now counts over 200 products and services. By working with SOLVO, you work with The Expert in the field of Transporter proteins.
Since 2018 SOLVO is part of the Citoxlab group. The Citoxlab Group offers a comprehensive range of preclinical services to meet the needs of pharmaceutical, biotechnology, medical device, chemical and agrochemical companies worldwide. Citoxlab carries out studies in general and reproductive toxicology, carcinogenicity, immunology, pharmacology, pharmacokinetics and bioanalysis/biomarkers and through AccelLAB the group provides efficacy and safety studies in medical devices (cardiology, ENT, orthopedics, and regenerative medicine). Today, Citoxlab has 1,300 employees working at nine sites with state-of-the-art facilities. The company has a world-class, top-level management team in scientific, financial and business activities. Click here to find out more about Citoxlab.